https://www.scienceboard.net/index.aspx?sec=log&itemID=5100
A new drug neutralizes SARS-CoV-2 and its variants by acting as an ACE2 receptor decoy, Dana-Farber Cancer Institute researchers revealed.
Create an account or login to join the discussion